India [August, 2025] – Terumo India, the Indian subsidiary of Terumo Corporation (TSE: 4543), a global leader in medical technology, has launched Terufusion™ Advanced Infusion Systems in India for the first time.
This connected infusion system combines a Smart Syringe Pump, Smart Infusion Pump (Volumetric), and Pump Monitoring System (PMS) software to enable precise and efficient drug administration.
Designed to enhance drug delivery accuracy, improve patient safety, and optimize clinical workflows, the system integrates Terumo's trusted global infusion technology with intelligent digital capabilities such as remote monitoring, customizable dose modes, and an integrated drug library.
Advancing Critical Care in India
As India's critical care infrastructure evolves with over 95,000 ICU beds and increasing investment in high-dependency care, there is a growing demand for smarter, safer, and more efficient drug delivery systems.
Terufusion™ Advanced Infusion Systems are designed to support hospitals in transitioning toward smarter, more transparent ICU operations.
Leadership Perspective
Mr. Shishir Agarwal, President and Managing Director, Terumo India, said:
"At Terumo India, our Brand Promise has always been about 'Unwavering Commitment to Patients'. With this launch, we are taking a meaningful step forward in bringing global innovation to support India's critical care infrastructure. Expanding into smart, connected technologies is a natural progression of our commitment to serve patients and healthcare providers more holistically, and to advance healthcare systems that are future-ready, inclusive, and clinically impactful."
Designed for Clinical Efficiency
The Terufusion™ Advanced Infusion Systems address everyday challenges faced by nursing staff by providing:
- Greater control and visibility in drug delivery
- Reduced manual errors through smart automation
- Simplified pump management across ICU environments
This advanced system enhances workflow efficiency while improving patient safety and confidence among healthcare professionals.
Terumo India is actively collaborating with leading hospitals across the country to implement Terufusion™ systems in advanced critical care management.
Mr. Dharampal Singh Rawat, Senior Director – Cardiovascular, Terumo Aortic and Medication Management, added:
"With evolving disease patterns and treatment timelines, clinicians must make faster decisions, and technology must support them. There is a growing need for solutions that combine precision with simplicity. Terufusion™ Advanced Infusion Systems are designed to help healthcare professionals deliver safer, more efficient care with confidence."
Commitment to Innovation
With this launch, Terumo India reinforces its commitment to equipping hospitals with intelligent, high-precision technologies that address the growing complexity of critical care.
In the past two years, the company has introduced several key innovations, including:
- TREO Abdominal Stent-Graft System
- Ultimaster Nagomi Drug-Eluting Stent
These innovations demonstrate Terumo's continued focus on delivering world-class, patient-centric healthcare solutions.
